361 participants
GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation in Monotherapy
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2016-12-12
- Start Date:
- 2008-05-31
- Completion:
- 2009-12-31
Conditions
- Diabetes Mellitus, Type 2
Interventions
- DRUG
- DEVICE